港股异动丨国联证券(01456.HK)急涨近17%创9个月新高 去年纯利预增9.4倍
格隆汇1月20日丨国联证券(01456.HK)股价急升,一度大涨近17%创9个月新高,现大涨10.89%,报2.85港元,暂成交322万港元,最新总市值54.2亿港元。国联证券17日发布公告,集团预期2019年归属于股东的净利润较2018年同期增加约940%。是由于公司证券投资业务实现良好投资回报;及受益于市场回升。12月底,国联证券设立香港子公司。业内人士指出,国联证券设立香港子公司,有利于提高盈利能力,在资管、投行等专业化服务领域中形成特色。值得注意的是,就在同一时间,国联证券宣布重启A股的IPO进程。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.